Reduced Serum Urate Concentrations Despite Unchanged Allopurinol Dosing in Gout Patients Commenced on Dialysis: A Retrospective Chart Review
Nephrology · 2026-03 · 31 (3)
DOI: 10.1111/nep.70184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology, online erschienen am 13.03.2026. Verfasst von Noha Kamel und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Faculty of Medicine & Health, The University of Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Allopurinol, Gout, Renal Dialysis, Uric Acid. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aim
People with kidney failure are at increased risk of gout‐related hospitalisations and mortality. Whilst dialysis enhances urate removal and reduces circulating oxypurinol (allopurinol's active metabolite), its effect on achieving target serum urate concentrations (< 0.36 mmol/L) and implications for gout management remain unclear. This study aimed to evaluate serum urate concentrations and allopurinol dosing following commencement of dialysis.
Methods
We conducted a retrospective chart review of adults prescribed allopurinol at a dialysis Centre in New South Wales, Australia, between 01/06/2019 and 30/06/2024. Eligible patients had at least one serum urate concentration recorded after commencing dialysis. Data collected included patient demographics, dialysis modality, allopurinol dosing, and serum urate concentrations, spanning from pre‐dialysis to up to 5 years post‐commencing dialysis.
Results
Forty‐five patients (18 haemodialysis [HD], 27 peritoneal dialysis [PD]) were included. Most HD patients (61%) received thrice‐weekly haemodiafiltration with high‐flux dialysers; 59% of PD patients used automated PD. Allopurinol doses (100–300 mg daily, mostly 100 mg) remained unchanged from pre‐dialysis in 93% (42/45). At 4 (0.25–38) months post‐dialysis, median serum urate concentrations declined compared to pre‐commencing dialysis (HD: 0.31 vs. 0.51 mmol/L, p = 0.031; PD: 0.33 vs. 0.53 mmol/L, p < 0.001). Target serum urate concentrations were reached at least once in 60% of HD and 78% of PD patients.
Conclusion
Serum urate concentrations declined after starting dialysis with unchanged allopurinol dosing, suggesting dialysis independently contributes to urate reduction. These findings support re‐evaluating allopurinol dose in patients after commencing dialysis, including de‐prescribing allopurinol in those who consistently achieve target urate concentrations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Faculty of Medicine & Health, The University of Sydney, New South Wales, Australia.
- Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
- Pharmacy Department, Blacktown Hospital, Sydney, New South Wales, Australia.
- Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.
- St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
- Nepean Clinical School, The University of Sydney, Sydney, New South Wales, Australia.
ORCID-Profile: Noha Kamel, Ronald Castelino, Daniel Wright, Kamal Sud, Surjit Tarafdar, Stephen Hughes, Sophie Stocker
Zitieren
APA
Kamel, N., Castelino, R., Wright, D., Sud, K., Tarafdar, S., Hughes, S., & Stocker, S. (2026). Reduced Serum Urate Concentrations Despite Unchanged Allopurinol Dosing in Gout Patients Commenced on Dialysis: A Retrospective Chart Review. Nephrology, 31(3). https://doi.org/10.1111/nep.70184
Vancouver
Kamel N, Castelino R, Wright D, Sud K, Tarafdar S, Hughes S, et al. Reduced Serum Urate Concentrations Despite Unchanged Allopurinol Dosing in Gout Patients Commenced on Dialysis: A Retrospective Chart Review. Nephrology. 2026;31(3). doi:10.1111/nep.70184
BibTeX
@article{Kamel2026,
author = {Kamel, Noha and Castelino, Ronald and Wright, Daniel and Sud, Kamal and Tarafdar, Surjit and Hughes, Stephen and Stocker, Sophie},
title = {Reduced Serum Urate Concentrations Despite Unchanged Allopurinol Dosing in Gout Patients Commenced on Dialysis: A Retrospective Chart Review},
journal = {Nephrology},
year = {2026},
volume = {31},
number = {3},
doi = {10.1111/nep.70184}
}
EUVIMED